Despite significant advancements in HIV treatment and prevention, researchers continue to seek a cure. This article explores ...

In 2012, the U.S. Food and Drugs Authority (FDA) had first approved Pre-Exposure Prophylaxis (PrEP) daily oral medicines for HIV prevention. More recently, long-acting injectable options of PrEP are ...

Nearly 40 million individuals globally are currently living with HIV, a virus that has resulted in the loss of over 42 ...

The department of virology & immunology, SIAHS, Srinivas University, successfully organized a National online webinar titled ...

FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

The FDA has approved Gilead Sciences' lenacapavir, sold as Yeztugo, as a biannual injection to prevent HIV, signaling a ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...

Central Florida faces one of the highest HIV prevalence rates in the nation, with over 14,000 individuals currently living ...